CONNEQT Health Limited (ASX:CQT)
Australia · Delayed Price · Currency is AUD 0.0170
-0.0010 (-5.56%)
At close: Sep 18, 2026
CONNEQT Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 6.3 | 3.55 | 10.91 | 4.6 | 4.07 |
Other Revenue | 1.66 | 2.5 | 1.91 | 1.09 | 0.67 |
| 7.96 | 6.05 | 12.81 | 5.69 | 4.74 | |
Revenue Growth | 31.50% | -52.76% | 125.14% | 20.12% | -14.11% |
Cost of Revenue | 1.69 | 1.82 | 0.8 | 0.91 | 1.01 |
Gross Profit | 6.27 | 4.23 | 12.02 | 4.79 | 3.73 |
Selling, General & Admin | 14.92 | 13.81 | 14 | 14.17 | 11.38 |
Research & Development | 0.74 | 2.21 | 2.49 | 3.91 | 2.38 |
Amortization of Goodwill & Intangibles | 0.21 | 0.1 | 0.01 | - | - |
Operating Expenses | 16.35 | 17.03 | 16.65 | 20.14 | 15.77 |
Operating Income | -10.08 | -12.8 | -4.63 | -15.35 | -12.04 |
Interest Expense | -0.58 | -0.66 | -1.18 | -0.41 | -0.23 |
Interest & Investment Income | - | 0 | 0.27 | 0.26 | 0.43 |
Earnings From Equity Investments | 0.02 | - | - | - | - |
Currency Exchange Gain (Loss) | - | 0.05 | 0.01 | 0.07 | 0.3 |
Other Non Operating Income (Expenses) | - | - | -0.44 | -3.45 | -0.28 |
EBT Excluding Unusual Items | -10.64 | -13.41 | -5.98 | -18.89 | -11.81 |
Gain (Loss) on Sale of Investments | -0.22 | -4.79 | -0.79 | - | - |
Pretax Income | -10.86 | -18.19 | -6.77 | -18.89 | -11.81 |
Net Income | -10.86 | -18.19 | -6.77 | -18.89 | -11.81 |
Net Income to Common | -10.86 | -18.19 | -6.77 | -18.89 | -11.81 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 603 | 354 | 201 | 130 | 103 |
Shares Outstanding (Diluted) | 603 | 354 | 201 | 130 | 103 |
Shares Change | 70.33% | 76.59% | 54.14% | 26.31% | 18.02% |
EPS (Basic) | -0.02 | -0.05 | -0.03 | -0.15 | -0.11 |
EPS (Diluted) | -0.02 | -0.05 | -0.03 | -0.15 | -0.12 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -9.73 | -10.92 | -7.84 | -12.05 | -9.57 |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.04 | -0.09 | -0.09 |
Gross Margin | 78.77% | 69.92% | 93.77% | 84.08% | 78.75% |
Operating Margin | -126.66% | -211.42% | -36.16% | -269.73% | -254.02% |
Profit Margin | -136.41% | -300.58% | -52.80% | -331.86% | -249.25% |
Free Cash Flow Margin | -122.20% | -180.45% | -61.19% | -211.80% | -202.02% |
EBITDA | -9.88 | -12.64 | -4.56 | -15.28 | -11.97 |
EBITDA Margin | -124.07% | -208.79% | -35.59% | -268.46% | -252.71% |
D&A For EBITDA | 0.21 | 0.16 | 0.07 | 0.07 | 0.06 |
EBIT | -10.08 | -12.8 | -4.63 | -15.35 | -12.04 |
EBIT Margin | -126.66% | -211.42% | -36.16% | -269.73% | -254.02% |
Revenue as Reported | 7.96 | 6.11 | 13.09 | 6.02 | 5.47 |